We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+12.04%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$1.16B
AUM Growth
+$114M
Cap. Flow
-$2.42M
Cap. Flow %
-0.21%
Top 10 Hldgs %
74.62%
Holding
64
New
Increased
1
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$79.3K

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$1.87M
2
BMY icon
Bristol-Myers Squibb
BMY
+$380K
3
ELV icon
Elevance Health
ELV
+$240K

Sector Composition

Rank Sector Weight
1 Financials 51.58%
2 Healthcare 17.23%
3 Materials 8.1%
4 Energy 7.63%
5 Technology 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRU icon
51
Prudential Financial
PRU
$42.2B
$745K 0.06%
6,350
IEX icon
52
IDEX
IEX
$17.5B
$661K 0.06%
2,710
ALPN
53
DELISTED
Alpine Immune Sciences Inc
ALPN
$493K 0.04%
12,445
VEEV icon
54
Veeva Systems
VEEV
$38.4B
$463K 0.04%
2,000
AVXL icon
55
Anavex Life Sciences
AVXL
$325M
$436K 0.04%
85,585
BN icon
56
Brookfield
BN
$110B
$419K 0.04%
15,000
VYM icon
57
Vanguard High Dividend Yield ETF
VYM
$83.8B
$294K 0.03%
2,430
USB icon
58
US Bancorp
USB
$100B
$237K 0.02%
5,300
OCUL icon
59
Ocular Therapeutix
OCUL
$2.14B
$155K 0.01%
17,000
CRVS icon
60
Corvus Pharmaceuticals
CRVS
$1.24B
$89K 0.01%
49,959
ALDX icon
61
Aldeyra Therapeutics
ALDX
$91.1M
$65K 0.01%
20,020
ELV icon
62
Elevance Health
ELV
$84.7B
-510
Closed -$240K

Similar funds

Hikari Power's Q1 2024 Portfolio in Review

As of Q1 2024, Hikari Power held 64 positions worth $1.16B, up 11% from $1.05B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 1.6%. Hikari Power opened no new positions and exited 1, leaving the 64-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 52% of assets, up from 50% a quarter earlier, followed by Healthcare and Materials.

  • Hikari Power added most to 3M in Q1 2024, an estimated $79.3K increase.
  • Hikari Power's biggest Q1 2024 reduction was Novo Nordisk, cutting an estimated $1.87M.
  • Hikari Power fully exited Elevance Health in Q1 2024, selling an estimated $240K.
  • Hikari Power's ten largest holdings make up 75% of its $1.16B portfolio in Q1 2024.
  • Hikari Power opened 0 new positions and closed 1 in Q1 2024.
  • Hikari Power's portfolio value rose 11% quarter-over-quarter to $1.16B.

Based on Hikari Power's 13F filing for Q1 2024, filed 8 May 2024.